The Patent Finder

Barbeau Pharma Inc.

Also on record
Records under this name other than patents Barbeau Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Barbeau Pharma Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,989,452Stable Hydrazalazine Pharmaceutical Compositions
Formerly held
Term ended
Term ended Oct 9, 2026 · High confidence
Term endedTerm ended Oct 9, 2026High confidence
US 7,220,858Synthesis of Hydrazine and Chlorinated Derivatives of Bicyclic Pyridazines
Formerly held
Term ended
Term ended Nov 6, 2024 · High confidence
Term endedTerm ended Nov 6, 2024High confidence
US 6,821,974Stable pharmaceutical compositions
Term ended
Term ended Mar 5, 2022 · USPTO record
Term endedTerm ended Mar 5, 2022USPTO record
US 6,825,196Stable pharmaceutical compositions
Lapsed on the fee record
Ended Nov 30, 2012 · USPTO record
Lapsed on the fee recordEnded Nov 30, 2012USPTO record
US 7,358,271Sulpiride pharmaceutical compositions
Formerly held
Lapsed on the fee record
Ended Apr 15, 2012 · USPTO record
Lapsed on the fee recordEnded Apr 15, 2012USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited